Bo O. Liu

Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Beyond conventional therapies: the evolution of targeted agents and immunotherapies in triple-negative breast cancer.

Beyond conventional therapies: the evolution of targeted agents and immunotherapies in triple-negative breast cancer.

Journal: Acta pharmacologica Sinica

Published: May 25, 2026

Decoding autophagy in neuro-tumor crosstalk: from underlying mechanisms to translational opportunities.

Decoding autophagy in neuro-tumor crosstalk: from underlying mechanisms to translational opportunities.

Journal: Theranostics

Published: March 22, 2026

Sodium taurocholate cotransporting polypeptide in HBV-related diseases: from underlying mechanisms to targeted therapies.

Sodium taurocholate cotransporting polypeptide in HBV-related diseases: from underlying mechanisms to targeted therapies.

Journal: Drug discovery today

Published: January 27, 2026

Drugging ERK1/2 in Cancer: A Glimpse of Small-Molecule Inhibitors.

Drugging ERK1/2 in Cancer: A Glimpse of Small-Molecule Inhibitors.

Journal: Medicinal research reviews

Published: November 04, 2025

Discovery of indolinone-based covalent ULK1 inhibitors that suppressed autophagy and induced apoptosis against colorectal carcinoma.

Discovery of indolinone-based covalent ULK1 inhibitors that suppressed autophagy and induced apoptosis against colorectal carcinoma.

Journal: European journal of medicinal chemistry

Published: October 22, 2025

Bromodomain containing protein 4 (BRD4) and cancer therapy: A glimpse at dual-target drug development.

Bromodomain containing protein 4 (BRD4) and cancer therapy: A glimpse at dual-target drug development.

Journal: Biochemical pharmacology

Published: August 27, 2025

Triple-Channel fluorescent probe for simultaneous detection of Cys, SO₂, and H₂S to discriminate Cancer cells via Transsulfuration pathway metabolic profiling.

Triple-Channel fluorescent probe for simultaneous detection of Cys, SO₂, and H₂S to discriminate Cancer cells via Transsulfuration pathway metabolic profiling.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: August 25, 2025

A "CPApoptosis" nano-actuator switches immune-off solid tumors to immune-on for fueling T-cell- based immunotherapy.

A "CPApoptosis" nano-actuator switches immune-off solid tumors to immune-on for fueling T-cell- based immunotherapy.

Journal: Theranostics

Published: October 26, 2024

LncRNA small nucleolar RNA host gene 1 (SNHG1) mediates acidic bile salt-induced EMT via the ULK1-Notch1 axis in Barrett's esophagus.

LncRNA small nucleolar RNA host gene 1 (SNHG1) mediates acidic bile salt-induced EMT via the ULK1-Notch1 axis in Barrett's esophagus.

Journal: Molecular biomedicine

Published: July 31, 2024

Deep learning identification of novel autophagic protein-protein interactions and experimental validation of Beclin 2-Ubiquilin 1 axis in triple-negative breast cancer.

Deep learning identification of novel autophagic protein-protein interactions and experimental validation of Beclin 2-Ubiquilin 1 axis in triple-negative breast cancer.

Journal: Oncology research

Published: July 10, 2024

Avicularin inhibits ferroptosis and improves cognitive impairments in Alzheimer's disease by modulating the NOX4/Nrf2 axis.

Avicularin inhibits ferroptosis and improves cognitive impairments in Alzheimer's disease by modulating the NOX4/Nrf2 axis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: June 25, 2024

Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer.

Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer.

Journal: Signal transduction and targeted therapy

Published: April 18, 2024

Showing 1-12 of 80

Last Updated: 09/26/2026